| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/01/1999 | EP0938498A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 09/01/1999 | EP0938497A1 Constrained helical peptides and methods of making same |
| 09/01/1999 | EP0938494A1 Inhibitors of protein farnesyl transferase |
| 09/01/1999 | EP0938492A1 Combinatorial synthesis of carbohydrate libraries |
| 09/01/1999 | EP0938487A2 2$i(R),4$i(S),$i(R),$i(S)- AND 2$i(S),4$i(R),$i(R),$i(S)-HYDROXYITRACONAZOLE- AND HYDROXYSAPERCONAZOLE DERIVATIVES |
| 09/01/1999 | EP0938484A1 2r,4s,r,r- and 2s,4r,r,r-hydroxyitraconazole |
| 09/01/1999 | EP0938475A1 Piperidine compounds |
| 09/01/1999 | EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/01/1999 | EP0938335A1 In ovo vaccination against newcastle disease |
| 09/01/1999 | EP0938331A1 Therapeutic uses of bpi protein products in cystic fibrosis patients |
| 09/01/1999 | EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/01/1999 | EP0938321A1 Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv |
| 09/01/1999 | EP0938315A1 Immune response modifier compounds for treatment of th2 mediated and related diseases |
| 09/01/1999 | EP0938312A1 Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia |
| 09/01/1999 | EP0938310A1 Anti-viral compounds |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0938298A1 Liposomes |
| 09/01/1999 | EP0938297A1 Immunomodulatory formulation |
| 09/01/1999 | EP0625160B1 Leukinferon preparation |
| 09/01/1999 | CN1227610A Antibodies against a complex of CD4 and a chemokine receptor domain, and their use against HIV infections |
| 09/01/1999 | CN1227565A Viral peptides with structural homology to protein G of respiratory syncytial virus |
| 09/01/1999 | CN1227564A Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227501A Long-acting drugs and pharmaceutical compositions comprising them |
| 09/01/1999 | CN1227493A The use of heparin or heparan sulfate in combination with chitosan for prevention or treatment of infections caused by herpes virus |
| 09/01/1999 | CN1227488A Improved method for preparing potassim clavulanate |
| 09/01/1999 | CN1227466A Substituted cyclopentane compounds useful as neuraminidase inhibitors |
| 09/01/1999 | CN1227225A Thiazole derivatives |
| 09/01/1999 | CN1227110A Hemostatic sterilizing agent |
| 09/01/1999 | CN1227101A Medicine synergist |
| 09/01/1999 | CN1044911C Method for preparing prodrug |
| 08/31/1999 | US5945577 Nuclear transfer units for cells |
| 08/31/1999 | US5945514 Mannose binding lectin bonded through hydrophylic high molecular weight chain to hydrophobic molecular weight chain; aerosols, creams, lotions for prophylactic use against human immunodeficiency viruses and others |
| 08/31/1999 | US5945446 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 08/31/1999 | US5945440 Indolocarbazole imides and the use thereof |
| 08/31/1999 | US5945414 Process for the preparation of new intermediates useful in the synthesis of cephalosporins |
| 08/31/1999 | US5945406 Anticancer agents; treatment for metastatic liver cancer, fungal infections, psoriasis; used in manufacture of drugsto prevent cell division |
| 08/31/1999 | US5945405 Crystal form O of clarithromycin |
| 08/31/1999 | US5945322 Several open reading frames from neisseria gonorrhoeae; for diagnosis and bactericides; for probes and primers |
| 08/31/1999 | US5945310 DNA encoding members of the IL-1 family, IL-1 delta |
| 08/31/1999 | US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases |
| 08/31/1999 | US5945124 Bactericide |
| 08/31/1999 | US5945116 Topical application of a mixture of rice bran fatty, coconut oil, caustic soda and sandalwood oil to human skin infected by viral tumors such as warts |
| 08/31/1999 | US5945102 Crustacean and fish derived multifunctional enzyme |
| 08/31/1999 | US5945032 Bactericides, disinfectants, hair cosmetics |
| 08/31/1999 | CA2173328C Hiv protease inhibitors |
| 08/31/1999 | CA2149765C Sequence-specific binding polymers for duplex nucleic acids |
| 08/31/1999 | CA2033447C Synergistic combination for treating herpes infections |
| 08/26/1999 | WO1999042603A1 GABAB-R2a, A 7TM RECEPTOR |
| 08/26/1999 | WO1999042588A2 Group b streptococcus antigens |
| 08/26/1999 | WO1999042564A2 Apoptotic cell-mediated antigen presentation to dendritic cells |
| 08/26/1999 | WO1999042562A1 NOVEL pgsA |
| 08/26/1999 | WO1999042485A1 Mucilage, a g-protein-coupled receptor |
| 08/26/1999 | WO1999042480A1 Analgesic peptides from venom of grammostola spatulata and use thereof |
| 08/26/1999 | WO1999042478A2 LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL32 |
| 08/26/1999 | WO1999042466A2 β-LACTAM-LIKE CHAPERONE INHIBITORS |
| 08/26/1999 | WO1999042441A1 Anti-retroviral functionalised aromatic compounds |
| 08/26/1999 | WO1999042136A1 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions |
| 08/26/1999 | WO1999042130A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 08/26/1999 | WO1999042121A1 Modified heat shock protein-antigenic peptide complex |
| 08/26/1999 | WO1999042119A1 Antimicrobial peptides and derived metapeptides |
| 08/26/1999 | WO1999042118A2 Compounds and methods for diagnosis of tuberculosis |
| 08/26/1999 | WO1999042115A1 Use of a press-juice, digestive juice or extract of carnivorous plants for inhibiting protein kinases |
| 08/26/1999 | WO1999042076A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/26/1999 | WO1999033989A3 Rantes mutants and therapeutic applications thereof |
| 08/26/1999 | WO1999031257A3 Protein expression in baculovirus vector expression systems |
| 08/26/1999 | WO1999028475A9 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 08/26/1999 | WO1999012944A3 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 08/26/1999 | DE19807972A1 New stable, water soluble calcium salts of cyclic lipopeptide antibiotics, useful as antibacterial agents |
| 08/26/1999 | CA2355117A1 .beta.-lactam-like chaperone inhibitors |
| 08/26/1999 | CA2337638A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/26/1999 | CA2322617A1 Compounds and methods for diagnosis of tuberculosis |
| 08/26/1999 | CA2321973A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 08/26/1999 | CA2321783A1 Use of an expressed juice, digestive juice or extract from flesh-eating plants for the inhibition of protein kinases |
| 08/26/1999 | CA2321219A1 Anti-retroviral functionalised aromatic compounds |
| 08/26/1999 | CA2321106A1 Group b streptococcus antigens |
| 08/26/1999 | CA2321101A1 Modified heat shock protein-antigenic peptide complex |
| 08/26/1999 | CA2319038A1 Analgesic peptides from venom of grammostola spatulata and use thereof |
| 08/26/1999 | CA2309943A1 Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions |
| 08/25/1999 | EP0937777A2 GABA receptors and their uses |
| 08/25/1999 | EP0937462A1 Vaccine compositions for mucosal delivery |
| 08/25/1999 | EP0937395A1 Disinfecting and sterilizing concentrate containing an aromatic dialdehyde and a neutral ph buffering system |
| 08/25/1999 | EP0937153A1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 08/25/1999 | EP0937143A2 Secreted proteins and polynucleotides encoding them |
| 08/25/1999 | EP0937093A2 1-galactose derivatives |
| 08/25/1999 | EP0937092A1 Solid support matrices containing a toxin binding oligosaccharide |
| 08/25/1999 | EP0937089A1 New knoevenagel condensation products, method for their production and their use |
| 08/25/1999 | EP0937084A1 Process for the preparation of salts and esters of clavulanic acid |
| 08/25/1999 | EP0937083A1 A crystalline substance of cefditoren pivoxyl and the production of the same |
| 08/25/1999 | EP0937079A1 Stabilized carbapenem antibiotic compositions and method of making |
| 08/25/1999 | EP0937078A1 Tricyclic carbapenem compounds |
| 08/25/1999 | EP0937071A1 2r,4s,s,s- and 2s,4r,s,s-hydroxyitraconazole |
| 08/25/1999 | EP0937070A1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 08/25/1999 | EP0937067A1 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as hiv protease inhibitors |
| 08/25/1999 | EP0937066A1 (4r,5s,6s,7r)-hexahydro-1- 5-(3-aminoinazole)methyl] -3-butyl-5,6-dihydroxy-4,7-bis phenylmethyl] -2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor |
| 08/25/1999 | EP0937045A1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 08/25/1999 | EP0936922A1 Polynucleotide vaccine formula for treating horse diseases |
| 08/25/1999 | EP0936920A1 NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS |
| 08/25/1999 | EP0936912A1 Inhibitors of cysteine protease |
| 08/25/1999 | EP0936909A1 Pharmaceutical composition for treating viral diseases |